U.S. federal trademark · Serial No. 50077528 · Reg. No. 019254532
Conducting of medical, scientific and clinical studies in the field of engineered T-cell receptor-based immunotherapy against solid cancer; conducting clinical trials and analyses in the field of engineered T-cell receptor-based immunotherapy against solid cancer, and providing corresponding information
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.